We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
Cap. Flow
-$702M
Cap. Flow %
-2.41%
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$407M
2
DXCM icon
DexCom
DXCM
+$326M
3
ROP icon
Roper Technologies
ROP
+$288M
4
PYPL icon
PayPal
PYPL
+$238M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$106M

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Healthcare 14.35%
3 Financials 13.74%
4 Consumer Discretionary 12.34%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTS
1051
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$69K ﹤0.01%
30,000
PLPM
1052
DELISTED
Planet Payment, Inc
PLPM
$63K ﹤0.01%
17,000
CFRX
1053
DELISTED
ContraFect Corporation
CFRX
$62K ﹤0.01%
31
AEG icon
1054
Aegon
AEG
$13.5B
$54K ﹤0.01%
18,000
-858
-5% -$2.56K
LYG icon
1055
Lloyds Banking Group
LYG
$89B
$53K ﹤0.01%
18,470
+6,169
+50% +$18.3K
CIE
1056
DELISTED
Cobalt International Energy, Inc
CIE
$50K ﹤0.01%
2,686
-57
-2% -$1.06K
SIRI icon
1057
SiriusXM
SIRI
$10.5B
$47K ﹤0.01%
1,144
-57
-5% -$2.38K
VHC icon
1058
VirnetX Holding Corp
VHC
$51M
$44K ﹤0.01%
+724
New +$45.4K
ROX
1059
DELISTED
Castle Brands, Inc.
ROX
$37K ﹤0.01%
42,500
BIOA.WS
1060
DELISTED
BioAmber Inc.
BIOA.WS
$32K ﹤0.01%
67,226
DARE icon
1061
Dare Bioscience
DARE
$19.8M
$31K ﹤0.01%
+250
New +$56K
VYNT
1062
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$28K ﹤0.01%
107
-13
-11% -$3.98K
AMPE
1063
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$25K ﹤0.01%
111
+55
+98% +$15.4K
OGEN icon
1064
Oragenics
OGEN
$2.26M
$23K ﹤0.01%
3
GLUU
1065
DELISTED
Glu Mobile Inc.
GLUU
$23K ﹤0.01%
10,336
+336
+3% +$778
VMEM
1066
DELISTED
VIOLIN MEMORY, INC.
VMEM
$16K ﹤0.01%
+22,500
New +$44.6K
FLNA
1067
Filana Therapeutics
FLNA
$43.5M
$12K ﹤0.01%
+1,686
New +$27.9K
CFRXW
1068
DELISTED
ContraFect Corporation Class A Warrants
CFRXW
$3K ﹤0.01%
25,000
PVCT
1069
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
20,000
KMI.WS
1070
DELISTED
Kinder Morgan Inc
KMI.WS
$1K ﹤0.01%
35,689
AA icon
1071
Alcoa
AA
$11.6B
-4,493
Closed -$100K
AMCX icon
1072
AMC Global Media
AMCX
$445M
-4,504
Closed -$272K
BKD icon
1073
Brookdale Senior Living
BKD
$3.69B
-18,479
Closed -$285K
CAPL icon
1074
CrossAmerica Partners
CAPL
$838M
-15,000
Closed -$368K
DBEF icon
1075
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.18B
-13,812
Closed -$345K

Similar funds

Brown Advisory's Q3 2016 Portfolio in Review

As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
  • Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
  • Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
  • Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
  • Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
  • Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
  • Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.

Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.